Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04713033 · ClinicalTrials.gov registry record
Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice
A clinical trial of Dysphonia, sponsored by NYU Langone Health.
- Completed
- Registry status
- 14
- Enrollment target
- 1
- Study location
NCT04713033 is a study of Dysphonia that has completed, run by NYU Langone Health. The registered enrollment target is 14 participants, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04713033, a study of Dysphonia, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool measuring functional cervical-cranial muscle network activity in typical and disordered speakers.The purpose of this study is to improve our understanding of how the vocal tract and the muscles of the larynx and the head work at baseline and after vocal fatigue.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST surface electromyogram (sEMG)
- DIAGNOSTIC_TEST flexible laryngoscopy
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-09-09 |
| Est. Completion | 2022-05-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04713033
The ClinicalTrials.gov registry entry for NCT04713033 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which surface electromyogram (sEMG) is the first listed.
NCT04713033 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04713033 about?
NCT04713033 is a clinical study titled "Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice". The long-term goal is to transform the diagnosis and treatment of dysphonia by elucidating cervical and cranial neuromuscular mechanisms underlying typical and disordered voicing. The overall objective of this application is to propose and evaluate a novel objective spectrotemporal diagnostic tool m...
What is the current status of trial NCT04713033?
This trial is currently completed. The enrollment target is 14 participants. The study started on 2021-09-09. Estimated completion is 2022-05-25.
What conditions does trial NCT04713033 study?
This clinical trial studies the following conditions: Dysphonia.
What interventions are being tested in trial NCT04713033?
The interventions under investigation include: surface electromyogram (sEMG) (DIAGNOSTIC_TEST), flexible laryngoscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04713033?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04713033 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
RECRUITING · NA
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
COMPLETED · NA
-
Silk Protein Microparticle-based Filler for Injection Augmentation
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.